Immunogenicity and safety of MF59-adjuvanted and full-dose unadjuvanted trivalent inactivated influenza vaccines among vaccine-naïve children in a randomized clinical trial in rural Senegal

INTRODUCTION: Effective, programmatically suitable influenza vaccines are needed for low-resource countries. MATERIALS AND METHODS: This phase II, placebo-controlled, randomized safety and immunogenicity trial (NCT01819155) was conducted in Senegal using the 2012–2013 Northern Hemisphere trivalent i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Vaccine
Egile Nagusiak: Diallo, Aldiouma, Victor, John C., Feser, Jodi, Ortiz, Justin R., Kanesa-thasan, Niranjan, Ndiaye, Moussa, Diarra, Bou, Cheikh, Sathie, Diene, Djibril, Ndiaye, Tofene, Ndiaye, Assane, Lafond, Kathryn E., Widdowson, Marc-Alain, Neuzil, Kathleen M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6327321/
https://ncbi.nlm.nih.gov/pubmed/30224199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2018.08.032
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak